This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n9http://linked.opendata.cz/resource/drugbank/drug/DB07482/identifier/pdb/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07482/identifier/pubchem-compound/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07482/identifier/pubchem-substance/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07482/identifier/drugbank/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB07482/identifier/chemspider/
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07482
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB07482 n13:DB07482
dcterms:title
(2R)-N-[(2R)-2-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-N-[(5R)-5-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-L-PROLINAMIDE
adms:identifier
n8:99443953 n9:BPR n10:10198228 n11:8373728 n12:DB07482
n3:IUPAC-Name
n4:271B48A1-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B48A7-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B48A6-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B48A3-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B48A4-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B48A5-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B489F-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B48A0-363D-11E5-9242-09173F13E4C5 n4:271B489D-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B489E-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B48AD-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B48AE-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B48A8-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B48A9-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B48AB-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B48AA-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B48AC-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B48B2-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B48B4-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B48B5-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B48B1-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B48B0-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B48B3-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B48A2-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B48AF-363D-11E5-9242-09173F13E4C5